天疱疮复发相关因素研究进展

doi:10.12144/zgmfskin202407514

China Journal of Leprosy and Skin Diseases ›› 2024, Vol. 40 ›› Issue (7): 514-518.doi: 10.12144/zgmfskin202407514

• Reviews • Previous Articles Next Articles

Update of factors related to pemphigus relapse

TANG Dongmei¹, GE Shiliang², YAN Yurou¹, LI Xiaolan¹

1 Department of Dermatology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China; 2 Department of Burn, The Second Affiliated Hospital of Kunming Medical University, Kunming 650000, China

Online:2024-07-15 Published:2024-06-12

Abstract

Abstract: Pemphigus is a life-threatening chronic autoimmune blistering disease, and glucocorticoids and immunosuppressive agents are common treatment. With the use of rituximab (RTX), there has been a significant improvement in the remission rate of pemphigus. However, relapses remain common due to various influencing factors and seriously affect the quality of patients. The latest research on factors associated with pemphigus relapse are reviewed in this paper provides.

Key words: pemphigus, anti-desmoglein, relapse factors, rituximab

TANG Dongmei, GE Shiliang, YAN Yurou, LI Xiaolan. Update of factors related to pemphigus relapse[J].China Journal of Leprosy and Skin Diseases, 2024, 40(7): 514-518.

[1]	WANG Xia, ZHANG Ting, ZHENG Jie, LOU Manman, YUAN Yongyong. A case of dermatological nursing care and perioperative management in a patient with pemphigus vulgaris complicated with malignant ascending colon tumor [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 362-364.
[2]	ZHANG Ying, NIU Xuping. Update of targeted treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 221-224.
[3]	ZHANG Kun, CHEN Lixiu. Bullous pemphigoid with positive pemphigus antibody in erythroderma: a case report [J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 606-608.
[4]	CHEN Yanmei, WANG Chuan, LIU Tingting, MI Zihao, SUN Lele, ZHAO Qing, WANG Na, LI Lichen, LIU Hong, ZHANG Furen. Expression of TLR4 and CXCR4 in patients with pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 327-331.
[5]	LONG Boquan, YANG Lan, MA Pingping, LAI Huijun, DOU Shuhui, CAI Chuanchuan, GUO Hongwei, LI Ding. Rituximab in the treatment of systemic lupus erythematosus with blood crisis: a case report [J]. China Journal of Leprosy and Skin Diseases, 2023, 39(12): 898-900.
[6]	CHEN Xue, TAN Cheng, SHAN Minjie, MIN Zhongsheng, JI Jin, CHEN Fang, LIU Qing, WU Hao, PAN Yongzheng. Rituximab combined with glucocorticoid in the treatment of refractory bullous pemphigoid: a case report [J]. China Journal of Leprosy and Skin Diseases, 2022, 38(3): 185-188.
[7]	WANG Yue, YAN Yulin. Analysis of risk factors for pemghigus vulgaris combined with acute pulmonary embolism [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 568-570.
[8]	YAO Xiangjun, ZHANG Qi, WANG Ting, FAN Min, LUO Zhen, WANG Peiguang, WANG Zaixing. Clinical features and etiological analysis of skin infection in 656 hospitalized patients with autoimmune bullous disease [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 494-498.
[9]	GUO Xinyun, WU Huihui, CHEN Lei, SUN Wenqi, FAN Chongshuai. Pemphigus vulgaris treated with oral tacrolimus combined with glucocorticoid: a case report [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 531-533.
[10]	FENG Xiaoran, LI Mengmeng, LI Jingyi, XUE Li. Minocycline hydrochloride combined with glucocorticoid in the treatment of herpetiform pemphigus: a case report [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 451-453.
[11]	XIE Zhimin, SHEN Xuchen, DAI Xiangnong, LI Qingqing, YE Xingdong. Update of non-desmoglein IgG autoantibodies in the pathogenesis of pemphigus vulgaris [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 324-327.
[12]	XU Jing, DENG Danqi. Upadate of biologicals for treating pemphigoid [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 328-331.
[13]	CAO Shan, YANG Baoqi. Update of comorbidities of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 809-812.
[14]	ZHAN Tongyin, CHEN Zerong, LAN Xiaomeng, SHRESTHA KRISTA, ZHANG Shouyue, LIU Hongjie, HU Nianfang, WANG Lian, LI Wei. Multiple autoimmune syndrome: a case report and literature review [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 94-96.
[15]	YANG Baoqi, ZHANG Zhaoxia, CHEN Mingfei, WANG Na, YAN Xiaoxiao, YANG Qing, PAN Futang, WANG Guangjin, DU Donghong, WU Mei, SHI Zhongxiang, ZHANG Furen. Treatment of pemphigus with rituximab: report of six cases and literature review [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 718-721.

Update of factors related to pemphigus relapse

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 10